Cell and Gene Therapy Market Report

China Cell and Gene Therapy Industry Market Research Report 2023-2029

  • POSTDATE：Sep 01, 2023
  • PAGES：226
  • REPORT CODE：GMM1770093
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Cell and Gene Therapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis AG

    • Orchard Therapeutics plc

    • ViroMed Co, Ltd

    • RENOVA THERAPEUTICS

    • Shanghai Sunway Biotech Co, Ltd,

    • Kite Pharma, Inc

    • Human Stem Cells Institute

    • Vericel Corporation

    • Spark Therapeutics, Inc

    • Sibiono GeneTech Co Ltd,

    • Pfizer, Inc

    • Amgen Inc

    • bluebird bio, Inc

    • Organogenesis Holdings Inc

    By Type:

    • Hematology

    • Cardiovascular

    • Neurology

    • Oncology

    • Ophthalmology

    • Rare Diseases

    • Other Therapeutic Classes

    By Application:

    • Hospital

    • Others

    • Pharmaceutical and Biotechnology Companies

    • Research and Academic Institutions

    • Contract Research Organizations (CROs)

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Cell and Gene Therapy Market Overview 2018-2029

    • 1.1 China Cell and Gene Therapy Industry Development Overview

    • 1.2 China Cell and Gene Therapy Industry Development History

    • 1.3 China Cell and Gene Therapy Industry Market Size (2018-2029)

    • 1.4 China Cell and Gene Therapy Market Analysis by Type from Production Side

      • 1.4.1 China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Hematology (2018-2029)

      • 1.4.2 China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Cardiovascular (2018-2029)

      • 1.4.3 China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Neurology (2018-2029)

      • 1.4.4 China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Oncology (2018-2029)

      • 1.4.5 China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Ophthalmology (2018-2029)

      • 1.4.6 China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Rare Diseases (2018-2029)

      • 1.4.7 China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Other Therapeutic Classes (2018-2029)

    • 1.5 China Cell and Gene Therapy Market Analysis by Application from Consumption End

      • 1.5.1 China Cell and Gene Therapy Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Cell and Gene Therapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Cell and Gene Therapy Sales Volume, Sales Value and Growth Rate of Pharmaceutical and Biotechnology Companies (2018-2029)

      • 1.5.4 China Cell and Gene Therapy Sales Volume, Sales Value and Growth Rate of Research and Academic Institutions (2018-2029)

      • 1.5.5 China Cell and Gene Therapy Sales Volume, Sales Value and Growth Rate of Contract Research Organizations (CROs) (2018-2029)

    • 1.6 China Cell and Gene Therapy Market Analysis by Region

      • 1.6.1 North China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

    Chapter 2 China Cell and Gene Therapy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Cell and Gene Therapy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Cell and Gene Therapy Market Status and Competition Analysis in 2023

      • 2.2.3 China Cell and Gene Therapy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Cell and Gene Therapy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Cell and Gene Therapy Industry Development

    Chapter 3 Cell and Gene TherapyIndustry Chain Analysis

    • 3.1 Cell and Gene Therapy Industry Chain

    • 3.2 Cell and Gene Therapy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Cell and Gene Therapy Market

    • 3.3 Cell and Gene Therapy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Cell and Gene Therapy Market

    Chapter 4 China Cell and Gene Therapy Market, by Type

    • 4.1 China Cell and Gene Therapy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Cell and Gene Therapy Total Production Volume and Growth Rate from Production Side

    • 4.5 China Cell and Gene Therapy Production Volume and Growth Rate, by Type

      • 4.5.1 China Cell and Gene Therapy Production Volume and Growth Rate of Hematology

      • 4.5.2 China Cell and Gene Therapy Production Volume and Growth Rate of Cardiovascular

      • 4.5.3 China Cell and Gene Therapy Production Volume and Growth Rate of Neurology

      • 4.5.4 China Cell and Gene Therapy Production Volume and Growth Rate of Oncology

      • 4.5.5 China Cell and Gene Therapy Production Volume and Growth Rate of Ophthalmology

      • 4.5.6 China Cell and Gene Therapy Production Volume and Growth Rate of Rare Diseases

      • 4.5.7 China Cell and Gene Therapy Production Volume and Growth Rate of Other Therapeutic Classes

    Chapter 5 China Cell and Gene Therapy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Cell and Gene Therapy Total Market Size and Growth Rate from Consumption End

    • 5.5 China Cell and Gene Therapy Market Size and Growth Rate, by Application

      • 5.5.1 China Cell and Gene Therapy Market Size and Growth Rate of Hospital

      • 5.5.2 China Cell and Gene Therapy Market Size and Growth Rate of Others

      • 5.5.3 China Cell and Gene Therapy Market Size and Growth Rate of Pharmaceutical and Biotechnology Companies

      • 5.5.4 China Cell and Gene Therapy Market Size and Growth Rate of Research and Academic Institutions

      • 5.5.5 China Cell and Gene Therapy Market Size and Growth Rate of Contract Research Organizations (CROs)

    Chapter 6 China Cell and Gene Therapy Market, by Region

    • 6.1 China Cell and Gene Therapy Production Volume and Production Value, by Region

    • 6.2 China Cell and Gene Therapy Sales Volume and Sales Value, by Region

    Chapter 7 North China Cell and Gene Therapy Market Analysis

    • 7.1 North China Cell and Gene Therapy Market, by Type

    • 7.2 North China Cell and Gene Therapy Market, by Application

    Chapter 8 Central China Cell and Gene Therapy Market Analysis

    • 8.1 Central China Cell and Gene Therapy Market, by Type

    • 8.2 Central China Cell and Gene Therapy Market, by Application

    Chapter 9 South China Cell and Gene Therapy Market Analysis

    • 9.1 South China Cell and Gene Therapy Market, by Type

    • 9.2 South China Cell and Gene Therapy Market, by Application

    Chapter 10 East China Cell and Gene Therapy Market Analysis

    • 10.1 East China Cell and Gene Therapy Market, by Type

    • 10.2 East China Cell and Gene Therapy Market, by Application

    Chapter 11 Northeast China Cell and Gene Therapy Market Analysis

    • 11.1 Northeast China Cell and Gene Therapy Market, by Type

    • 11.2 Northeast China Cell and Gene Therapy Market, by Application

    Chapter 12 Southwest China Cell and Gene Therapy Market Analysis

    • 12.1 Southwest China Cell and Gene Therapy Market, by Type

    • 12.2 Southwest China Cell and Gene Therapy Market, by Application

    Chapter 13 Northwest China Cell and Gene Therapy Market Analysis

    • 13.1 Northwest China Cell and Gene Therapy Market, by Type

    • 13.2 Northwest China Cell and Gene Therapy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis AG

        • 14.1.1 Novartis AG Company Profile

        • 14.1.2 Novartis AG Cell and Gene Therapy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Orchard Therapeutics plc

        • 14.2.1 Orchard Therapeutics plc Company Profile

        • 14.2.2 Orchard Therapeutics plc Cell and Gene Therapy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 ViroMed Co, Ltd

        • 14.3.1 ViroMed Co, Ltd Company Profile

        • 14.3.2 ViroMed Co, Ltd Cell and Gene Therapy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 RENOVA THERAPEUTICS

        • 14.4.1 RENOVA THERAPEUTICS Company Profile

        • 14.4.2 RENOVA THERAPEUTICS Cell and Gene Therapy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Shanghai Sunway Biotech Co, Ltd,

        • 14.5.1 Shanghai Sunway Biotech Co, Ltd, Company Profile

        • 14.5.2 Shanghai Sunway Biotech Co, Ltd, Cell and Gene Therapy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Kite Pharma, Inc

        • 14.6.1 Kite Pharma, Inc Company Profile

        • 14.6.2 Kite Pharma, Inc Cell and Gene Therapy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Human Stem Cells Institute

        • 14.7.1 Human Stem Cells Institute Company Profile

        • 14.7.2 Human Stem Cells Institute Cell and Gene Therapy Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Vericel Corporation

        • 14.8.1 Vericel Corporation Company Profile

        • 14.8.2 Vericel Corporation Cell and Gene Therapy Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Spark Therapeutics, Inc

        • 14.9.1 Spark Therapeutics, Inc Company Profile

        • 14.9.2 Spark Therapeutics, Inc Cell and Gene Therapy Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Sibiono GeneTech Co Ltd,

        • 14.10.1 Sibiono GeneTech Co Ltd, Company Profile

        • 14.10.2 Sibiono GeneTech Co Ltd, Cell and Gene Therapy Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Pfizer, Inc

        • 14.11.1 Pfizer, Inc Company Profile

        • 14.11.2 Pfizer, Inc Cell and Gene Therapy Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Amgen Inc

        • 14.12.1 Amgen Inc Company Profile

        • 14.12.2 Amgen Inc Cell and Gene Therapy Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 bluebird bio, Inc

        • 14.13.1 bluebird bio, Inc Company Profile

        • 14.13.2 bluebird bio, Inc Cell and Gene Therapy Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Organogenesis Holdings Inc

        • 14.14.1 Organogenesis Holdings Inc Company Profile

        • 14.14.2 Organogenesis Holdings Inc Cell and Gene Therapy Market Performance

        • 14.14.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Cell and Gene Therapy Industry Research Conclusions

    • 15.2 Cell and Gene Therapy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Cell and Gene Therapy Industry Market Size (2018-2029)

    • Figure China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Hematology (2018-2029)

    • Figure China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Cardiovascular (2018-2029)

    • Figure China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Neurology (2018-2029)

    • Figure China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Oncology (2018-2029)

    • Figure China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Ophthalmology (2018-2029)

    • Figure China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Rare Diseases (2018-2029)

    • Figure China Cell and Gene Therapy Production Volume, Production Value and Growth Rate of Other Therapeutic Classes (2018-2029)

    • Figure China Cell and Gene Therapy Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Cell and Gene Therapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Cell and Gene Therapy Sales Volume, Sales Value and Growth Rate of Pharmaceutical and Biotechnology Companies (2018-2029)

    • Figure China Cell and Gene Therapy Sales Volume, Sales Value and Growth Rate of Research and Academic Institutions (2018-2029)

    • Figure China Cell and Gene Therapy Sales Volume, Sales Value and Growth Rate of Contract Research Organizations (CROs) (2018-2029)

    • Figure North China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

    • Figure Central China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

    • Figure South China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

    • Figure East China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Cell and Gene Therapy Market Size and Growth Rate from 2018-2029

    • Figure Cell and Gene Therapy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Cell and Gene Therapy Market Share by Type in 2018

    • Figure China Cell and Gene Therapy Market Share by Type in 2023

    • Figure China Cell and Gene Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Cell and Gene Therapy Production Volume and Growth Rate of Hematology (2018-2023)

    • Figure China Cell and Gene Therapy Production Volume and Growth Rate of Cardiovascular (2018-2023)

    • Figure China Cell and Gene Therapy Production Volume and Growth Rate of Neurology (2018-2023)

    • Figure China Cell and Gene Therapy Production Volume and Growth Rate of Oncology (2018-2023)

    • Figure China Cell and Gene Therapy Production Volume and Growth Rate of Ophthalmology (2018-2023)

    • Figure China Cell and Gene Therapy Production Volume and Growth Rate of Rare Diseases (2018-2023)

    • Figure China Cell and Gene Therapy Production Volume and Growth Rate of Other Therapeutic Classes (2018-2023)

    • Figure China Cell and Gene Therapy Market Share by Application in 2018

    • Figure China Cell and Gene Therapy Market Share by Application in 2023

    • Figure China Cell and Gene Therapy Total Market Size and Growth Rate from Consumption End

    • Figure China Cell and Gene Therapy Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Cell and Gene Therapy Market Size and Growth Rate of Others (2018-2023)

    • Figure China Cell and Gene Therapy Market Size and Growth Rate of Pharmaceutical and Biotechnology Companies (2018-2023)

    • Figure China Cell and Gene Therapy Market Size and Growth Rate of Research and Academic Institutions (2018-2023)

    • Figure China Cell and Gene Therapy Market Size and Growth Rate of Contract Research Organizations (CROs) (2018-2023)

    • Table China Cell and Gene Therapy Production Volume by Region (2018-2023)

    • Table China Cell and Gene Therapy Production Volume Share by Region (2018-2023)

    • Figure China Cell and Gene Therapy Production Volume Share by Region (2018-2023)

    • Table China Cell and Gene Therapy Production Value by Region (2018-2023)

    • Table China Cell and Gene Therapy Production Value Share by Region (2018-2023)

    • Figure China Cell and Gene Therapy Production Value Share by Region (2018-2023)

    • Table China Cell and Gene Therapy Sales Volume by Region (2018-2023)

    • Table China Cell and Gene Therapy Sales Volume Share by Region (2018-2023)

    • Figure China Cell and Gene Therapy Sales Volume Share by Region (2018-2023)

    • Table China Cell and Gene Therapy Sales Value by Region (2018-2023)

    • Table China Cell and Gene Therapy Sales Value Share by Region (2018-2023)

    • Figure China Cell and Gene Therapy Sales Value Share by Region (2018-2023)

    • Table North China Cell and Gene Therapy Production Volume by Type (2018-2023)

    • Table North China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Figure North China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Table North China Cell and Gene Therapy Sales Volume by Application (2018-2023)

    • Table North China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Figure North China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Table Central China Cell and Gene Therapy Production Volume by Type (2018-2023)

    • Table Central China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Figure Central China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Table Central China Cell and Gene Therapy Sales Volume by Application (2018-2023)

    • Table Central China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Figure Central China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Table South China Cell and Gene Therapy Production Volume by Type (2018-2023)

    • Table South China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Figure South China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Table South China Cell and Gene Therapy Sales Volume by Application (2018-2023)

    • Table South China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Figure South China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Table East China Cell and Gene Therapy Production Volume by Type (2018-2023)

    • Table East China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Figure East China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Table East China Cell and Gene Therapy Sales Volume by Application (2018-2023)

    • Table East China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Figure East China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Table Northeast China Cell and Gene Therapy Production Volume by Type (2018-2023)

    • Table Northeast China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Figure Northeast China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Table Northeast China Cell and Gene Therapy Sales Volume by Application (2018-2023)

    • Table Northeast China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Table Southwest China Cell and Gene Therapy Production Volume by Type (2018-2023)

    • Table Southwest China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Figure Southwest China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Table Southwest China Cell and Gene Therapy Sales Volume by Application (2018-2023)

    • Table Southwest China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Table Northwest China Cell and Gene Therapy Production Volume by Type (2018-2023)

    • Table Northwest China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Figure Northwest China Cell and Gene Therapy Production Volume Share by Type (2018-2023)

    • Table Northwest China Cell and Gene Therapy Sales Volume by Application (2018-2023)

    • Table Northwest China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Cell and Gene Therapy Sales Volume Share by Application (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table Orchard Therapeutics plc Company Profile

    • Table Orchard Therapeutics plc Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table ViroMed Co, Ltd Company Profile

    • Table ViroMed Co, Ltd Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table RENOVA THERAPEUTICS Company Profile

    • Table RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table Shanghai Sunway Biotech Co, Ltd, Company Profile

    • Table Shanghai Sunway Biotech Co, Ltd, Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table Kite Pharma, Inc Company Profile

    • Table Kite Pharma, Inc Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table Human Stem Cells Institute Company Profile

    • Table Human Stem Cells Institute Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table Vericel Corporation Company Profile

    • Table Vericel Corporation Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table Spark Therapeutics, Inc Company Profile

    • Table Spark Therapeutics, Inc Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table Sibiono GeneTech Co Ltd, Company Profile

    • Table Sibiono GeneTech Co Ltd, Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table Amgen Inc Company Profile

    • Table Amgen Inc Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table bluebird bio, Inc Company Profile

    • Table bluebird bio, Inc Cell and Gene Therapy Revenue, Price and Gross (2018-2023)

    • Table Organogenesis Holdings Inc Company Profile

    • Table Organogenesis Holdings Inc Cell and Gene Therapy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US